Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Informatics » COVID-19 Immune Response to be Mapped by Adaptive Biotechnologies, Microsoft

COVID-19 Immune Response to be Mapped by Adaptive Biotechnologies, Microsoft

Mar 20, 2020
|
staff reporter

NEW YORK – Adaptive Biotechnologies and Microsoft are expanding their existing partnership on mapping adaptive immune responses population-wide to include COVID-19, the companies said on Friday.

Beginning in April, Adaptive will collect de-identified blood samples from patients diagnosed with or recovered from COVID-19. It will sequence the samples and map the immune cell receptor profiles to antigens from SARS-CoV-2, the virus that causes COVID-19. The partners will then upload the immune response signatures to an open-access data portal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Shift to New Variant Work

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

Victim Identified with Genetic Genealogy

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

PNAS Papers on Chemotherapy-Induced Cardiac Injury Target, Viral Insertions, SMRT Methylation Profiling

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Should Also Work

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.

Jan
28
Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Sponsored by
Sophia Genetics

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources. 

Feb
11
Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Sponsored by
Foundation Medicine

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb
17
Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Sponsored by
BioLegend

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Feb
18
Featured Webinar

Single-Cell Multiomics to Elucidate Immune Alterations in the Human Tumor Microenvironment

Sponsored by
BD

The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression. 

What's Popular?

In Sequencing

  1. Thermo Fisher Scientific, SPT Labtech to Comarket Sequencing Library Prep Products

  2. Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

  3. Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

    Premium

  4. Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

  5. Fresenius Building Large Renal Genomic Registry to Inform Precision Care for Kidney Disease

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.